Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

• Asıl Yazarlar: Dongxuan Li (Yazar), Chunmeng Qin (Yazar), Hongli Wang (Yazar), Dan Du (Yazar), Yalan Wang (Yazar), Qian Du (Yazar), Songqing Liu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: SAGE Publishing, 2024-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: The use of antineoplastic agents is one of the important triggers of tumor lysis syndrome (TLS), but there is still a lack of comprehensive understanding of antineoplastic agents that may trigger TLS and the TLS risk differences between different antineoplastic agents. Objectives: This s...